Sign In
Buy EVGN
$0.599
+0.0089 (+1.51%)
At Close: Jun 03, 2026
Lavie Bio Announces the Appointment of Russ Putland as Vice President Commercial
07:00am, Tuesday, 25'th May 2021
REHOVOT, Israel, May 25, 2021 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company focusing on improving food quality, sustainability, and agriculture productivity through the introduction
Evogene Financial Results and Earnings Announcement Schedule for the First Quarter of 2021
07:00am, Wednesday, 12'th May 2021
REHOVOT, Israel, May 12, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several
Biomica to Present at Jefferies Microbiome-Based Therapeutics Summit, on April 22nd, 2021
07:00am, Monday, 19'th Apr 2021
REHOVOT, Israel, April 19, 2021 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd.
EVGN Stock: Over 9% Increase Pre-Market Explanation
08:34am, Tuesday, 13'th Apr 2021
The stock price of Evogene Ltd. (Nasdaq: EVGN) increased by over 9% pre-market.
Biomica Announces Positive Pre-Clinical Results, Demonstrating Efficacy of BMC128 in Melanoma
07:00am, Tuesday, 13'th Apr 2021
REHOVOT, Israel, April 13, 2021 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd.
Evogene's Canonic Positioned To Enter Israeli Medical Cannabis Market
01:05pm, Wednesday, 07'th Apr 2021
Canonic, a subsidiary of Evogene, has a strategy to enter the Israeli medical cannabis market. Canonic, using Evogene's CPB platform, is developing innovative cannabis strains to meet industry needs.
Evogene to Hold Virtual Investor & Analyst Days
07:00am, Wednesday, 07'th Apr 2021
REHOVOT, Israel, April 7, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company today announced that it will hold virtual investor and analyst days,
Evogene Files Annual Report for the Year Ended December 31, 2020
02:55pm, Friday, 02'nd Apr 2021
REHOVOT, Israel , April 2, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company focused on revolutionizing product discovery and development in multip
Canonic of Evogene Group and Tikun Olam (Israel)-Cannbit, sign production and distribution agreements for Canonic products in Israel
03:00am, Thursday, 25'th Mar 2021
REHOVOT, Israel and TEL-AVIV, Israel, March 25, 2021 /PRNewswire/ -- Canonic Ltd., a subsidiary of Evogene Ltd.
Evogene's Subsidiary Biomica: Impressive Pre-Clinical Data For Its Microbiome Therapeutic BMC128
06:02pm, Wednesday, 17'th Mar 2021
Biomica released impressive pre-clinical data for its rationally designed 4 strand microbiome therapeutic candidate BMC128 in immuno-oncology presented at the 5th Annual European Microbiome Drug Devel
Evogene Ltd. (EVGN) CEO Ofer Haviv on Q4 2020 Results - Earnings Call Transcript
03:02pm, Wednesday, 03'rd Mar 2021
Evogene Ltd. (EVGN) CEO Ofer Haviv on Q4 2020 Results - Earnings Call Transcript
Evogene: Ambitious Computational Biology Company Aims To Reward Patient Investors
02:03pm, Thursday, 25'th Feb 2021
Evogene Ltd. is a leading computational biology company aiming to "revolutionize" the discovery and development of life sciences products covering human health, agriculture, and industrial purposes.
TEL AVIV and REHOVOT, Israel, Feb. 24, 2021 /PRNewswire/ -- Cannbit Ltd., a subsidiary of Tikun Olam-Cannbit Ltd. (TASE: TKUN), a leading medical cannabis company, and Canonic Ltd., a subsidiary of Ev
BiomX Inc.: Clinical Stage Phage Therapeutics Company Looks Promising
11:08am, Monday, 22'nd Feb 2021
BiomX Inc.: Clinical Stage Phage Therapeutics Company Looks Promising
REHOVOT, Israel, Jan. 20, 2021 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN)
